Dilated Cardiomyopathy 1o C1837839
A genetic heart condition where the main pumping chamber enlarges and weakens, reducing blood flow. It can run in families. Treatment includes medications, pacemakers, or heart transplant.
Key facts at a glance
- ICD-10
- B33.24
- ICD-11
- 1A00.0
- Body system
- cardiovascular
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Chest discomfort or palpitations
(cardiovascular)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Dyspnea (shortness of breath)
(cardiovascular)Fatigue
(cardiovascular)Peripheral edema
(cardiovascular)Palpitations
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Disease management and monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
ACE Inhibitors
ACE inhibitors are first-line medications that reduce cardiac workload by dilating blood vessels and decreasing blood pressure. They help prevent adverse cardiac remodeling and improve survival outcomes in dilated cardiomyopathy patients.
Beta-Blockers
Beta-blockers slow heart rate and reduce myocardial oxygen demand, helping the heart pump more efficiently. They are essential for managing symptoms and improving long-term prognosis in heart failure patients.
Additional treatment options
Sodium Restriction
Limiting dietary sodium intake helps reduce fluid retention and decreases cardiac workload. Patients should avoid processed foods and read labels to manage daily sodium consumption.
lifestyleEchocardiogram Surveillance
Regular echocardiographic monitoring tracks changes in ejection fraction and chamber dimensions. This helps guide treatment adjustments and identifies patients who may need device therapy.
monitoringICD Evaluation
Implantable cardioverter-defibrillator evaluation assesses candidacy for primary prevention of sudden cardiac death. Risk stratification considers ejection fraction and arrhythmia history.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Dilated Cardiomyopathy 1o C1837839?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Dilated Cardiomyopathy 1o C1837839. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy